Targeting the miR-200c/LIN28B axis in acquired EGFR-TKI resistance non-small cell lung cancer cells harboring EMT features
Hiroki Sato(Tokyo Medical University), Shinichi Toyooka(Okayama University Hospital)
Cited by 60
Related Papers
Tumor Analyses Reveal Squamous Transformation and Off-Target Alterations As Early Resistance Mechanisms to First-line Osimertinib in <i>EGFR</i> -Mutant Lung Cancer
|Clinical Cancer Research|2020|381